These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 30366316)

  • 21. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
    Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
    Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives.
    Pedrood K; Sherafati M; Mohammadi-Khanaposhtani M; Asgari MS; Hosseini S; Rastegar H; Larijani B; Mahdavi M; Taslimi P; Erden Y; Günay S; Gulçin İ
    Int J Biol Macromol; 2021 Feb; 170():1-12. PubMed ID: 33352155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors.
    Javaid K; Saad SM; Rasheed S; Moin ST; Syed N; Fatima I; Salar U; Khan KM; Perveen S; Choudhary MI
    Bioorg Med Chem; 2015 Dec; 23(23):7417-21. PubMed ID: 26552899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives.
    Asadi M; Ahangari MM; Iraji A; Azizian H; Nokhbehzaim A; Bahadorikhalili S; Mojtabavi S; Faramarzi MA; Nasli-Esfahani E; Larijani B; Mahdavi M; Amanlou M
    Sci Rep; 2024 Jul; 14(1):17338. PubMed ID: 39069559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
    Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
    Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
    Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
    Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.
    Yousefnejad F; Mohammadi-Moghadam-Goozali M; Sayahi MH; Halimi M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Asadi M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2023 Jul; 13(1):12397. PubMed ID: 37524733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.
    Adib M; Peytam F; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Larijani B; Moghadamnia AA; Esfahani EN; Bandarian F; Mahdavi M
    Bioorg Med Chem Lett; 2019 Mar; 29(5):713-718. PubMed ID: 30661823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
    Wang G; Chen M; Qiu J; Xie Z; Cao A
    Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents.
    Emadi M; Halimi M; Moazzam A; Hosseini S; Mojtabavi S; Faramarzi MA; Ghadimi R; Moghadamnia AA; Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Mahdavi M
    Sci Rep; 2023 Jun; 13(1):10030. PubMed ID: 37340010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
    Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI
    Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.
    Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS
    Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives.
    Gong Z; Peng Y; Qiu J; Cao A; Wang G; Peng Z
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28914795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.